RxDoctor Payments Data

Octavio Ramilo

Pediatric Infectious Diseases · Memphis, TNNPI 1710947395

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Pfizer at 49.7% of the total. 2025 is the largest year on record at $206,136, more than ten times the $13,822 reported in 2019. Among pediatric infectious diseases clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$413,234in general payments, 2019–2025

Across 170 payments — averaging $2430.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$205K
  • Merck$107K
  • Sanofi Pasteur Inc.$69K
  • Modernatx, Inc.$22K
  • Astrazeneca UK Limited$6K
  • Pfizer Chile S.A.$2K
  • plus $3K from 2 others
$303,643in research payments, 2019–2025

Across 17 payments — averaging $17,861 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$208K
  • Biofire Diagnostics, LLC$48K
  • AstraZeneca$43K
  • Astrazeneca UK Limited$5K

What the payments were for

  • Consulting fees$166,78340%
  • Speaking & faculty fees$112,18227%
  • Travel & lodging$131,21532%
  • Food & beverage$3,0541%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer(2 entities)66$205,406
Merck79$106,689
Sanofi Pasteur Inc.19$68,572
Modernatx, Inc.1$21,817
Astrazeneca UK Limited1$6,000
Pfizer Chile S.A.2$2,050
Eli Lilly1$1,575
AstraZeneca1$1,125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$413,234 in reported general payments places this provider in the 95th percentile of 36 pediatric infectious diseases providers in Tennessee.

See all pediatric infectious diseases providers in Tennessee →

Other pediatric infectious diseases in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →